CN105461656A - Novel process for preparation of 1-[2-(2,4-dimethylphenylsulphanyl)phenyl] piperazine - Google Patents

Novel process for preparation of 1-[2-(2,4-dimethylphenylsulphanyl)phenyl] piperazine Download PDF

Info

Publication number
CN105461656A
CN105461656A CN201510761975.0A CN201510761975A CN105461656A CN 105461656 A CN105461656 A CN 105461656A CN 201510761975 A CN201510761975 A CN 201510761975A CN 105461656 A CN105461656 A CN 105461656A
Authority
CN
China
Prior art keywords
add
aprotic solvent
dissolved
reaction
room temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510761975.0A
Other languages
Chinese (zh)
Inventor
闫起强
赵国磊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Wanquan Dezhong Medical Biological Technology Co Ltd
Original Assignee
Beijing Wanquan Dezhong Medical Biological Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Wanquan Dezhong Medical Biological Technology Co Ltd filed Critical Beijing Wanquan Dezhong Medical Biological Technology Co Ltd
Priority to CN201510761975.0A priority Critical patent/CN105461656A/en
Publication of CN105461656A publication Critical patent/CN105461656A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Abstract

The present invention discloses a novel process for the preparation of 1-[2-(2,4-dimethylphenylsulphanyl)phenyl] piperazine. The process uses o-halogenated benzenesulfonic acid and m-xylene as raw materials, which are subjected to dehydration condensation with methylsulfonic acid and phosphorus pentoxide as condensing agents to generate halogenated diarylsulfone. Halogenated diarylsulfone and piperazine are subjected to a substitution reaction in an aprotic solvent to produce piperazine ring substituted diarylsulfone; the piperazine ring substituted diarylsulfone is reduced by hexachlorodisilane in an aprotic solvent to obtain a product with high yield. This method has the advantages of cheap and easily available raw materials, avoidance of the usage of a noble metal catalyst and treatment of residual palladium, simple operation, mild reaction conditions, simple post-treatment, and potential application values.

Description

A kind ofly prepare the fertile novel process for Xi Ting
Technical field
The present invention relates to medicinal chemistry art, be specifically related to prepare the fertile novel process for Xi Ting.
Background technology
Fertile for western spit of fland chemistry 1-[2-(2 by name, 4-3,5-dimethylphenyl) sulfydryl] phenyl]-piperazine, it is serotonin transporter inhibitor, and Active Regulation is carried out to its acceptor, developed jointly by Ling Bei and military field, obtain U.S. FDA approval listing in September, 2013, trade(brand)name Brintellix, is clinically used for the treatment of major depressive disorder and breadth first algorithm.
Current Yuan Yan company discloses the preparation method (WO2007144005, CN101472906) of this compound, and this compound has three kinds of synthetic methods, and reaction scheme is as follows:
Method 1:
This reaction process has three steps, and wherein two-step reaction all uses palladium source, and cost is relatively high, is unsuitable for suitability for industrialized production.
Method 2:
Reaction process is one kettle way, and reaction process is fairly simple, but reaction process cannot effectively control, and a lot of side reaction may occur, the more difficult control of quality product
Method 3:
This reaction is two steps, although reaction process is fairly simple, operation is also relatively easy, reaction process uses palladium noble metal catalyst, is not suitable for suitability for industrialized production, and this patent has been authorized and entered, and need consider patent evasion.
Summary of the invention
In order to solve the problem existing for existing preparation method, the invention discloses the fertile novel process for Xi Ting of preparation, this method avoid use noble metal catalyst, raw material is cheap and easy to get, and reaction conditions is gentle, is beneficial to suitability for industrialized production.
Particular content is as follows:
Join in toluene solvant by bromothiophenol and N methyl piperazine, add salt of wormwood, be heated to 100 ~ 120 DEG C of backflows, reflection is spent the night, bromothiophenol and N methyl piperazine generation halogenating reaction, after question response terminates, stops heating, is cooled to room temperature.Aftertreatment obtains intermediate 1.Wherein temperature of reaction preferably 120 DEG C.
Intermediate 1 and 2,4-dimethyl iodobenzene are joined in toluene solvant, under nitrogen protection, adds Pddba 2and rac-BINAP.Add NaOBu t.Be heated to 100 ~ 120 DEG C of backflows, reaction is spent the night.After question response terminates, aftertreatment obtains intermediate 2.Wherein temperature of reaction preferably 100 DEG C.
Intermediate 2 is dissolved in aprotic solvent, adds a certain amount of phenyl chloroformate, stirring at room temperature 4-18h, after question response terminates.Be cooled to room temperature, add moisture and go out organic phase, aqueous phase toluene extracts three times, and merge organic phase and obtain oily matter, underpressure distillation obtains intermediate 3.Wherein aprotic solvent is selected from acetone, tetrahydrofuran (THF), dioxane, preferred tetrahydrofuran (THF).Phenyl chloroformate add-on is 1-3 times of intermediate 2 mole number.
Intermediate 3 is dissolved in aprotic solvent, adds salt of wormwood, stirring heating, reaction 1-24h, preferred reaction 8h; After question response terminates.Be cooled to room temperature, aftertreatment obtains fertile for Xi Ting.Wherein aprotic solvent is selected from acetone, tetrahydrofuran (THF), dioxane, preferred acetone.
Its technical process is as follows:
Concrete embodiment
Following example is to describe the present invention in detail, but should not be construed as limiting the invention.
Embodiment 1:
Bromothiophenol (4.7g, 25mmol) and N methyl piperazine (2.5g, 25mmol) are dissolved in 60ml toluene solvant, be heated to 120 DEG C, reaction is spent the night, bromothiophenol and N methyl piperazine generation halogenating reaction, after question response terminates, stop heating, be cooled to room temperature.Add 50ml water, filter to isolate aqueous phase, organic phase saturated aqueous common salt and clear water washing, merge aqueous phase toluene and extract.Removed under reduced pressure toluene, obtains intermediate 1, product 4.4g, yield 85%.
Embodiment 2:
By intermediate 1(4.2g, 20mmol) be dissolved in 40ml toluene, add 2,4-dimethyl iodobenzene (4.6g, 20mmol), add Pddba 2,rac-BINAP and NaOBu t.Reflux to 100 DEG C, reaction is spent the night.After reaction terminates, stop heating, be cooled to room temperature.Add water, filter to isolate aqueous phase, organic phase salt solution and clear water washing, merge aqueous phase toluene and extract.Removed under reduced pressure toluene, obtains intermediate 2.Product 5.4g, yield 87%.
Embodiment 3:
By intermediate 2(3.1g, 10mmol) and phenyl chloroformate (1.6g, 10mmol) in, be dissolved in 30mL tetrahydrofuran (THF), stirring at room temperature 4h, after question response terminates.Be cooled to room temperature, reaction solution joins in 200mL water, stirred at ambient temperature 2 hours, filters, is washed to neutrality, dry product 3.8g, productive rate 91%.
Embodiment 4:
By intermediate 3(4.2g, 10mmol) be dissolved in acetone 20mL, add salt of wormwood, stirring heating, reaction 8h, after question response terminates.Be cooled to room temperature, reaction solution joins in 200mL water, stirred at ambient temperature 2 hours, filters, is washed to neutrality, obtains product 2.8g, yield 94%.

Claims (7)

1. prepare a fertile novel process for Xi Ting, its operational path is as follows:
(1) be dissolved in toluene solvant by bromothiophenol and N methyl piperazine, add salt of wormwood, reacting by heating is spent the night, and after question response terminates, stop heating, be cooled to room temperature, aftertreatment obtains intermediate 1;
(2) intermediate 1 and 2,4-dimethyl iodobenzene are joined in toluene solvant, under nitrogen protection, add Pddba 2and rac-BINAP, add NaOBu t, reflux, reaction is spent the night, and after question response terminates, aftertreatment obtains intermediate 2;
(3) intermediate 2 is dissolved in aprotic solvent, adds a certain amount of phenyl chloroformate, stirring at room temperature 4-18h, after question response terminates, be cooled to room temperature, add moisture and go out organic phase, aqueous phase toluene extracts three times, and merge organic phase and obtain oily matter, underpressure distillation obtains intermediate 3;
(4) be dissolved in aprotic solvent by intermediate 3, add salt of wormwood, stirring heating, reaction 1-24h, after question response terminates, is cooled to room temperature, and aftertreatment obtains fertile for Xi Ting.
2. method as claimed in claim 1, step (1) is characterized in that: join in toluene solvant by bromothiophenol and N methyl piperazine, add salt of wormwood, is heated to 100 ~ 120 DEG C of backflows; Wherein preferable reaction temperature is 120 DEG C.
3. method as claimed in claim 1, step (2) is characterized in that: join in toluene solvant by intermediate 1 and 2,4-dimethyl iodobenzene, under nitrogen protection, add Pddba 2and rac-BINAP, add NaOBu t, be heated to 100 ~ 120 DEG C of backflows; Wherein preferable reaction temperature is 100 DEG C.
4. method as claimed in claim 1, step (3) is characterized in that: be dissolved in aprotic solvent by intermediate 2, and wherein aprotic solvent is selected from acetone, tetrahydrofuran (THF), dioxane, preferred tetrahydrofuran (THF).
5. method as described in claim 1,4, is characterized in that, phenyl chloroformate add-on is 1-3 times of intermediate 2 mole number.
6. method as claimed in claim 1, step (4) is characterized in that: be dissolved in aprotic solvent by intermediate 3, and wherein aprotic solvent is selected from the one in acetone, tetrahydrofuran (THF) and dioxane, preferred acetone.
7. method as described in claim 1,6, is characterized in that the reaction times is 1-24h, preferred 8h.
CN201510761975.0A 2015-11-11 2015-11-11 Novel process for preparation of 1-[2-(2,4-dimethylphenylsulphanyl)phenyl] piperazine Pending CN105461656A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510761975.0A CN105461656A (en) 2015-11-11 2015-11-11 Novel process for preparation of 1-[2-(2,4-dimethylphenylsulphanyl)phenyl] piperazine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510761975.0A CN105461656A (en) 2015-11-11 2015-11-11 Novel process for preparation of 1-[2-(2,4-dimethylphenylsulphanyl)phenyl] piperazine

Publications (1)

Publication Number Publication Date
CN105461656A true CN105461656A (en) 2016-04-06

Family

ID=55599873

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510761975.0A Pending CN105461656A (en) 2015-11-11 2015-11-11 Novel process for preparation of 1-[2-(2,4-dimethylphenylsulphanyl)phenyl] piperazine

Country Status (1)

Country Link
CN (1) CN105461656A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105622546A (en) * 2016-01-07 2016-06-01 美吉斯制药(厦门)有限公司 Preparation method for vortioxetine
WO2017215636A1 (en) * 2016-06-16 2017-12-21 广东东阳光药业有限公司 Diaryl sulphide piperazine compound and preparation method and use thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105541759A (en) * 2016-01-07 2016-05-04 美吉斯制药(厦门)有限公司 Novel method for preparing vortioxetine
CN105622546A (en) * 2016-01-07 2016-06-01 美吉斯制药(厦门)有限公司 Preparation method for vortioxetine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105541759A (en) * 2016-01-07 2016-05-04 美吉斯制药(厦门)有限公司 Novel method for preparing vortioxetine
CN105622546A (en) * 2016-01-07 2016-06-01 美吉斯制药(厦门)有限公司 Preparation method for vortioxetine

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105622546A (en) * 2016-01-07 2016-06-01 美吉斯制药(厦门)有限公司 Preparation method for vortioxetine
CN105622546B (en) * 2016-01-07 2020-08-28 万全万特制药(厦门)有限公司 Preparation method of vortioxetine
WO2017215636A1 (en) * 2016-06-16 2017-12-21 广东东阳光药业有限公司 Diaryl sulphide piperazine compound and preparation method and use thereof
JP2019525900A (en) * 2016-06-16 2019-09-12 サンシャイン・レイク・ファーマ・カンパニー・リミテッドSunshine Lake Pharma Co.,Ltd. Diarylthioether piperazine compounds, their preparation and use
US10927089B2 (en) 2016-06-16 2021-02-23 Sunshine Lake Pharma Co., Ltd. Diaryl thioether piperazine compounds, preparation methods and uses thereof

Similar Documents

Publication Publication Date Title
AU2011281421A1 (en) Process for preparing aminobenzoylbenzofuran derivatives
CN103242197B (en) Preparation method of ultraviolet absorbent intermediate etocrilene (ETO)
CN101798271B (en) Method for preparing (+/-)-norepinephrine
CN104356092A (en) Preparation method for vortioxetine
CN105461656A (en) Novel process for preparation of 1-[2-(2,4-dimethylphenylsulphanyl)phenyl] piperazine
CN102827010B (en) Novel beta-aminopropanoic acid synthesis technology
CN104725335A (en) Preparation method of high-purity vortioxetine hydrobromide
CN110563735A (en) Method for preparing florasulam
CN105566162A (en) Rilpivirine midbody preparing technology
CN106065005B (en) Preparation method of R- (+) -2- [4- (hydroxyphenoxy) ] propionate
CN105348220A (en) Synthetic method for vortioxetine hydrobromide
CN103145796B (en) Synthesis process of neotame
CN113264843A (en) Synthetic method of 3-aminobicyclo [1.1.1] pentane-1-carboxylic ester derivative
KR101744046B1 (en) Process for preparing an intermediate useful for the synthesis of silodosin
WO2020127887A1 (en) Process for the preparation of an intermediate product of ivosidenib
CN108164423B (en) Preparation method of naftifine hydrochloride
WO2016146049A1 (en) Industrial preparation method of midazolam
CN109608344A (en) A kind of preparation method of (R) -3- amino butanol
CN106278914B (en) A kind of synthesis technique of increase production of amines
CN110878082B (en) Gatifloxacin and its synthesis method
CN104109135A (en) Preparation method of 1-[2-(2,4-dimethyl phenylsulfanyl)-phenyl]piperazine
KR101404616B1 (en) Method for Preparation of γ-fluorinated ketone derivatives
CN110386936B (en) Preparation method of 4-chloro-7H-pyrrolo [2,3-d ] pyrimidine
CN108911991B (en) Method for producing 2,3, 4-trifluoroaniline by solvent-free catalytic hydrogenation method
Shen et al. An efficient synthesis of enantiomerically pure trans-N1, N2-dimethylcyclohexane-1, 2-diamine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160406

WD01 Invention patent application deemed withdrawn after publication